NCT04640350

Brief Summary

Through the parameters of liver stiffness and spleen stiffness obtained by combi-elastography technique, summarize and analyze the warning index of esophagogastric variceal bleeding in patients with cirrhosis, so as to provide a new and valuable technique for clinical diagnosis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 10, 2020

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 23, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

December 31, 2020

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2023

Completed
Last Updated

January 19, 2021

Status Verified

January 1, 2021

Enrollment Period

2 years

First QC Date

November 10, 2020

Last Update Submit

January 13, 2021

Conditions

Keywords

Elasticity Imaging TechniquesUltrasound

Outcome Measures

Primary Outcomes (3)

  • F index

    F index is linked to the degree of liver fibrosis,and it can be available by ultrasound elastography checking.

    baseline

  • A index

    A index is linked to the degree of hepatitis ,and it can be available by ultrasound elastography checking.

    baseline

  • Spleen stiffness

    Spleen stiffness can be available by ultrasound elastography checking.

    baseline

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with liver cirrhosis and the gastroscopy is in line with the indications of portal hypertension.

You may qualify if:

  • years old, no gender limit;
  • The clinical diagnosis is in line with patients with liver cirrhosis caused by chronic hepatitis B, and the gastroscopy is in line with the indications of portal hypertension;
  • Gastroscopy needs to provide the degree of gastroesophageal varices;
  • Sign the informed consent form.

You may not qualify if:

  • Patients with cirrhosis and portal hypertension because of other causes or combined with other causes(such as viral hepatitis other than hepatitis B,Autoimmune liver disease, alcoholic liver disease, metabolism-related fatty liver disease, etc.)
  • Patients with a history of spleen-related operations, such as splenectomy, splenic embolism;
  • Patients undergoing portosystemic shunt or TIPS;
  • Isolated esophageal venous tumor and its bleeding patients;
  • History of upper gastrointestinal tumor or bleeding from gastric ulcer , etc;
  • Those with serious diseases of other systems that cannot cooperate with elastography examination, such as heart failure, renal failure, mental illness, etc;
  • Ascites before liver and spleen result unable to complete elasticity examination;
  • Pregnant patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chinese PLA General Hospital

Beijing, Beijing Municipality, 100853, China

RECRUITING

MeSH Terms

Conditions

Liver Cirrhosis

Condition Hierarchy (Ancestors)

Liver DiseasesDigestive System DiseasesFibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Ping Liang, Doctor

    Chinese PLA General Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief physician

Study Record Dates

First Submitted

November 10, 2020

First Posted

November 23, 2020

Study Start

December 31, 2020

Primary Completion

December 31, 2022

Study Completion

May 31, 2023

Last Updated

January 19, 2021

Record last verified: 2021-01

Locations